Concepedia

Marina Faedi

MF

Statistics

Publications

20

Citations

1.4K

H-Index

17

Active since

1983

Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico(Current)

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Istituto Oncologico Veneto

University of Turin

Guglielmo da Saliceto Hospital

Marina Faedi is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in oncology, medicine, and chemotherapy.

Publications per year

1983–2021

20

Publications

20

Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial

Giuseppe Lombardi, Gian Luca De Salvo, Alba A. Brandes et al. · The Lancet Oncology · 2018 · 386 citations

Medicine, Oncology, Pharmacology +13

Systematic versus on-demand early palliative care: A randomised clinical trial assessing quality of care and treatment aggressiveness near the end of life

Marco Maltoni, Emanuela Scarpi, Monia Dall’Agata et al. · European Journal of Cancer · 2016 · 187 citations · Full text

Medicine, Oncology, End-of-life Care +8

Systematic versus on-demand early palliative care: results from a multicentre, randomised clinical trial

Marco Maltoni, Emanuela Scarpi, Monia Dall’Agata et al. · European Journal of Cancer · 2016 · 174 citations · Full text

Medicine, Oncology, End-of-life Care +10

Trastuzumab-induced cardiotoxicity in early breast cancer patients: a retrospective study of possible risk and protective factors

Alberto Farolfi, Elisabetta Melegari, Michele Aquilina et al. · Heart · 2013 · 108 citations

Medicine, Oncology, Pharmacology +17

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

Sabino De Placido, Ciro Gallo, Michelino De Laurentiis et al. · The Lancet Oncology · 2018 · 88 citations · Full text

Medicine, Endocrinology, Oncology +11

1–5 of 20